Actuate Therapeutics Inc. Live Share Price Today, Share Analysis and Chart

Name: Actuate Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Actuate Therapeutics Inc.
Rating: 1.03825
Author: Trendlyne DVM scores

about

Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglu...

5.97 -0.23 (-3.71%)

50.21% Fall from 52W High

45,608

XNAS Volume

XNAS 15 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

0.0 / 100

Technically Neutral

41.5 / 100

No estimates available

Actuate Therapeutics Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Actuate Therapeutics Inc. Live Share Price Today, Share Analysis and Chart

Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglu...

50.21% Fall from 52W High

SWOT Analysis

Actuate Therapeutics Inc. Live Price Chart